Status | Study |
Recruiting |
Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT Condition: Primary Immunodeficiency Syndromes Congenital Bone Marrow Failure Syndromes Date: 2013-10-10 Interventions: Drug: Hydroxyurea Hydroxyurea |
Recruiting |
Study Name: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Condition: SCID Omenn's Syndrome Reticul Date: 2012-07-25 Interventions: Drug: Alemtuzumab 0.3 mg 0.3 m |
Recruiting |
Study Name: Patients Treated for SCID (1968-2010) Condition: SCID ADA-SCID XSCID Leak Date: 2011-04-29 |
Recruiting |
Study Name: Natural History Study of SCID Disorders Condition: SCID Leaky SCID Omenn Syndrome Date: 2010-08-20 |
Completed |
Study Name: Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders Condition: Non Malignant Disorders Immunodeficiencies Congenital Marr Date: 2008-08-28 Interventions: Biological: Unrelated Umbilical Cord Blood Transplant |